Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Dec;9(12):3831-7.
doi: 10.1002/j.1460-2075.1990.tb07601.x.

Increased eIF-2 alpha expression in mitogen-activated primary T lymphocytes

Affiliations

Increased eIF-2 alpha expression in mitogen-activated primary T lymphocytes

R B Cohen et al. EMBO J. 1990 Dec.

Abstract

G0 human T cells synthesize protein at low rates and contain very low levels of eIF-2 alpha mRNA. eIF-2 alpha plays a pivotal role in the earliest regulated steps of translation initiation. We examined eIF-2 alpha gene expression in normal human T cells stimulated with PHA. Nuclear run-on assays indicate low rates of eIF-2 alpha gene transcription in G0 cells and these change 2-fold with PHA treatment. Actinomycin D chase experiments show that the t1/2 of eIF-2 alpha mRNA is similar in G0 and PHA-treated T cells. Analysis of nuclear RNA with probes specific for eIF-2 alpha intron sequences shows that increased eIF-2 alpha expression after PHA treatment is largely due to intranuclear stabilization of the primary transcript. The increase in eIF-2 alpha mRNA does not require new protein synthesis. Hence, expression of this gene appears to be a part of the primary response program of T cells when they are exposed to mitogen.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Mol Biol. 1985 Mar 5;182(1):109-29 - PubMed
    1. FEBS Lett. 1980 Aug 11;117(1):284-8 - PubMed
    1. J Cell Physiol. 1988 Aug;136(2):215-25 - PubMed
    1. Transplant Proc. 1987 Feb;19(1 Pt 1):331-2 - PubMed
    1. J Exp Med. 1985 Jun 1;161(6):1593-8 - PubMed

MeSH terms